118 research outputs found

    Spectral Sequences and Khovanov Homology

    Get PDF
    In this thesis, we will focus on two main topics; the common thread between both will be the existence of spectral sequences relating Khovanov homology to other knot invariants. Our first topic is an invariant MKh(L) for links in thickened disks with multiple punctures. This invariant is different from but inspired by both the Asaeda-Pryzytycki-Sikora (APS) homology and its specialization to links in the solid torus. Our theory will be constructed from a Z^n-filtration on the Khovanov complex, and as a result we will get various spectral sequences relating MKh(L) to Kh(L), AKh(L), and APS(L). Our second topic is the Dowlin spectral sequence, which has E_2-page isomorphic to the reduced Khovanov homology Kh(L), and which converges to the knot Floer homology HFK(L) on the E_infinity-page. While it was previously known that these two pages are link invariants, we prove that every page is an invariant by defining weak maps on the underlying filtered complex which correspond to Reidemeister moves. This result is based on joint work with Samuel Tripp

    Анализ использования золошлакового материала Красноярской ТЭЦ-2 для получения товарного продукта

    Get PDF
    Объектом исследования в работе являются технологии утилизации золы с получением товарного продукта. Целью выпускной квалификационной работы является выполнение аналитического обзора литературных данных по использованию золошлаковых отходов, складируемых на золоотвале №2 Красноярской ТЭЦ -2, с целью производства товарного продукта. В процессе исследования проводился аналитический обзор по литературным источникам с целью выяснения достижений мировой науки техники в рассматриваемой области. В результате исследования разработана технологическая схема переработки золы и шлака в продукт для дальнейшего использования в отрасли производства строительных материалов.The object of research in the work are the technologies for the utilization of ash to obtain a marketable product. The aim of the final qualification work is to perform an analytical review of the literature on the use of ash and slag waste stored at ash dump No. 2 of the Krasnoyarsk power plant 2, with the aim of producing a marketable product. In the course of the study, an analytical review of literary sources was carried out in order to ascertain the achievements of the world science of technology in the field under consideration. As a result of the study, a technological scheme was developed for processing ash and slag into a product for further use in the building materials industry

    ARF and p53 coordinate tumor suppression of an oncogenic IFN-β-STAT1-ISG15 signaling axis

    Get PDF
    SummaryThe ARF and p53 tumor suppressors are thought to act in a linear pathway to prevent cellular transformation in response to various oncogenic signals. Here, we show that loss of p53 leads to an increase in ARF protein levels, which function to limit the proliferation and tumorigenicity of p53-deficient cells by inhibiting an IFN-β-STAT1-ISG15 signaling axis. Human triple-negative breast cancer (TNBC) tumor samples with coinactivation of p53 and ARF exhibit high expression of both STAT1 and ISG15, and TNBC cell lines are sensitive to STAT1 depletion. We propose that loss of p53 function and subsequent ARF induction creates a selective pressure to inactivate ARF and propose that tumors harboring coinactivation of ARF and p53 would benefit from therapies targeted against STAT1 and ISG15 activation

    Anticancer Gene Transfer for Cancer Gene Therapy

    Get PDF
    Gene therapy vectors are among the treatments currently used to treat malignant tumors. Gene therapy vectors use a specific therapeutic transgene that causes death in cancer cells. In early attempts at gene therapy, therapeutic transgenes were driven by non-specific vectors which induced toxicity to normal cells in addition to the cancer cells. Recently, novel cancer specific viral vectors have been developed that target cancer cells leaving normal cells unharmed. Here we review such cancer specific gene therapy systems currently used in the treatment of cancer and discuss the major challenges and future directions in this field

    Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases

    Get PDF
    Neuroinflammation is a process characterised by drastic changes in microglial morphology and by marked upregulation of the 18-kDa translocator protein (TSPO) on the mitochondria. The continual increase in incidence of neuroinflammation and neurodegenerative diseases poses a major health issue in many countries, requiring more innovative diagnostic and monitoring tools. TSPO expression may constitute a biomarker for brain inflammation that could be monitored by using TSPO tracers as neuroimaging agents. From medical imaging perspectives, this review focuses on the current concepts related to the TSPO, and discusses briefly on the status of its PET imaging related to neuroinflammation and neurodegenerative diseases in humans

    Early Detection of Erlotinib Treatment Response in NSCLC by 3′-Deoxy-3′-[18F]-Fluoro-L-Thymidine ([18F]FLT) Positron Emission Tomography (PET)

    Get PDF
    Background: Inhibition of the epidermal growth factor receptor (EGFR) has shown clinical success in patients with advanced non-small cell lung cancer (NSCLC). Somatic mutations of EGFR were found in lung adenocarcinoma that lead to exquisite dependency on EGFR signaling; thus patients with EGFR-mutant tumors are at high chance of response to EGFR inhibitors. However, imaging approaches affording early identification of tumor response in EGFR-dependent carcinomas have so far been lacking. Methodology/Principal Findings: We performed a systematic comparison of 3′-Deoxy-3′-[18F^{18}F]-fluoro-L-thymidine ([18F^{18}F]FLT) and 2-[18F^{18}F]-fluoro-2-deoxy-D-glucose ([18F^{18}F]FDG) positron emission tomography (PET) for their potential to identify response to EGFR inhibitors in a model of EGFR-dependent lung cancer early after treatment initiation. While erlotinib-sensitive tumors exhibited a striking and reproducible decrease in [18F^{18}F]FLT uptake after only two days of treatment, [18F^{18}F]FDG PET based imaging revealed no consistent reduction in tumor glucose uptake. In sensitive tumors, a decrease in [18F^{18}F]FLT PET but not [18F^{18}F]FDG PET uptake correlated with cell cycle arrest and induction of apoptosis. The reduction in [18F^{18}F]FLT PET signal at day 2 translated into dramatic tumor shrinkage four days later. Furthermore, the specificity of our results is confirmed by the complete lack of [18F^{18}F]FLT PET response of tumors expressing the T790M erlotinib resistance mutation of EGFR. Conclusions: [18F^{18}F]FLT PET enables robust identification of erlotinib response in EGFR-dependent tumors at a very early stage. [18F^{18}F]FLT PET imaging may represent an appropriate method for early prediction of response to EGFR TKI treatment in patients with NSCLC
    corecore